Skip to content

Cigna Group

NYSE: CI · USD

Cigna Group financials

6 charts

Revenue

USD millions

$71,668M
Cigna Group Revenue. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodRevenue
FY 2019 Q1$37,946M; Change unavailable vs FY 2018 Q4
FY 2019 Q2$38,819M; +2.3% vs FY 2019 Q1
FY 2019 Q3$38,556M; −0.7% vs FY 2019 Q2
FY 2019 Q4$38,245M; −0.8% vs FY 2019 Q3
FY 2020 Q1$38,469M; +0.6% vs FY 2019 Q4
FY 2020 Q2$39,265M; +2.1% vs FY 2020 Q1
FY 2020 Q3$40,955M; +4.3% vs FY 2020 Q2
FY 2020 Q4$41,712M; +1.8% vs FY 2020 Q3
FY 2021 Q1$40,971M; −1.8% vs FY 2020 Q4
FY 2021 Q2$43,131M; +5.3% vs FY 2021 Q1
FY 2021 Q3$44,288M; +2.7% vs FY 2021 Q2
FY 2021 Q4$45,688M; +3.2% vs FY 2021 Q3
FY 2022 Q1$44,005M; −3.7% vs FY 2021 Q4
FY 2022 Q2$45,480M; +3.4% vs FY 2022 Q1
FY 2022 Q3$45,280M; −0.4% vs FY 2022 Q2
FY 2022 Q4$45,751M; +1.0% vs FY 2022 Q3
FY 2023 Q1$46,517M; +1.7% vs FY 2022 Q4
FY 2023 Q2$48,586M; +4.4% vs FY 2023 Q1
FY 2023 Q3$49,048M; +1.0% vs FY 2023 Q2
FY 2023 Q4$51,114M; +4.2% vs FY 2023 Q3
FY 2024 Q1$57,255M; +12.0% vs FY 2023 Q4
FY 2024 Q2$60,523M; +5.7% vs FY 2024 Q1
FY 2024 Q3$63,694M; +5.2% vs FY 2024 Q2
FY 2024 Q4$65,649M; +3.1% vs FY 2024 Q3
FY 2025 Q1$65,502M; −0.2% vs FY 2024 Q4
FY 2025 Q2$67,178M; +2.6% vs FY 2025 Q1
FY 2025 Q3$69,748M; +3.8% vs FY 2025 Q2
FY 2025 Q4$72,472M; +3.9% vs FY 2025 Q3
FY 2026 Q1$68,494M; −5.5% vs FY 2025 Q4
FY 2026 Q2$71,668M; +4.6% vs FY 2026 Q1
Dec 31, 2018 through Sep 25, 2026

Net income

USD millions

$1,660M
Cigna Group Net income. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodNet income
FY 2019 Q1$1,372M; Change unavailable vs FY 2018 Q4
FY 2019 Q2$1,410M; +2.8% vs FY 2019 Q1
FY 2019 Q3$1,354M; −4.0% vs FY 2019 Q2
FY 2019 Q4$984M; −27.3% vs FY 2019 Q3
FY 2020 Q1$1,189M; +20.8% vs FY 2019 Q4
FY 2020 Q2$1,760M; +48.0% vs FY 2020 Q1
FY 2020 Q3$1,398M; −20.6% vs FY 2020 Q2
FY 2020 Q4$4,142M; +196.3% vs FY 2020 Q3
FY 2021 Q1$1,171M; −71.7% vs FY 2020 Q4
FY 2021 Q2$1,476M; +26.0% vs FY 2021 Q1
FY 2021 Q3$1,635M; +10.8% vs FY 2021 Q2
FY 2021 Q4$1,133M; −30.7% vs FY 2021 Q3
FY 2022 Q1$1,198M; +5.7% vs FY 2021 Q4
FY 2022 Q2$1,572M; +31.2% vs FY 2022 Q1
FY 2022 Q3$2,778M; +76.7% vs FY 2022 Q2
FY 2022 Q4$1,198M; −56.9% vs FY 2022 Q3
FY 2023 Q1$1,306M; +9.0% vs FY 2022 Q4
FY 2023 Q2$1,510M; +15.6% vs FY 2023 Q1
FY 2023 Q3$1,449M; −4.0% vs FY 2023 Q2
FY 2023 Q4$1,107M; −23.6% vs FY 2023 Q3
FY 2024 Q1$-212M; −119.2% vs FY 2023 Q4
FY 2024 Q2$1,629M; +868.4% vs FY 2024 Q1
FY 2024 Q3$825M; −49.4% vs FY 2024 Q2
FY 2024 Q4$1,536M; +86.2% vs FY 2024 Q3
FY 2025 Q1$1,409M; −8.3% vs FY 2024 Q4
FY 2025 Q2$1,632M; +15.8% vs FY 2025 Q1
FY 2025 Q3$1,973M; +20.9% vs FY 2025 Q2
FY 2025 Q4Unavailable; Change unavailable vs FY 2025 Q3
FY 2026 Q1$1,654M; Change unavailable vs FY 2025 Q4
FY 2026 Q2$1,660M; +0.4% vs FY 2026 Q1

Net margin

%

2.32%
Cigna Group Net margin. Reported fiscal history.
Fiscal period%
FY 2019 Q13.62%
FY 2019 Q23.63%
FY 2019 Q33.51%
FY 2019 Q42.57%
FY 2020 Q13.09%
FY 2020 Q24.48%
FY 2020 Q33.41%
FY 2020 Q49.93%
FY 2021 Q12.86%
FY 2021 Q23.42%
FY 2021 Q33.69%
FY 2021 Q42.48%
FY 2022 Q12.72%
FY 2022 Q23.46%
FY 2022 Q36.14%
FY 2022 Q42.62%
FY 2023 Q12.81%
FY 2023 Q23.11%
FY 2023 Q32.95%
FY 2023 Q42.17%
FY 2024 Q1-0.37%
FY 2024 Q22.69%
FY 2024 Q31.3%
FY 2024 Q42.34%
FY 2025 Q12.15%
FY 2025 Q22.43%
FY 2025 Q32.83%
FY 2025 Q4—
FY 2026 Q12.41%
FY 2026 Q22.32%

P/E

× · TTM · Daily

—
Cigna Group P/E. Monthly closing observations; inspect daily values with the chart arrow keys.
Close date× · TTM · DailyFinancials through
2019-03-2915.26×2018-12-31
2019-04-3015.07×2018-12-31
2019-05-3114.05×2018-12-31
2019-06-2814.95×2018-12-31
2019-07-3116.12×2018-12-31
2019-08-3014.61×2018-12-31
2019-09-3014.4×2018-12-31
2019-10-3116.93×2018-12-31
2019-11-2918.97×2018-12-31
2019-12-3119.4×2018-12-31
2020-01-3118.25×2018-12-31
2020-02-2813.48×2019-12-31
2020-03-3113.05×2019-12-31
2020-04-3014.42×2019-12-31
2020-05-2915.03×2020-03-31
2020-06-3014.3×2020-03-31
2020-07-3113.16×2020-03-31
2020-08-3112.49×2020-06-30
2020-09-3011.93×2020-06-30
2020-10-3011.76×2020-06-30
2020-11-3014.49×2020-09-30
2020-12-3114.42×2020-09-30
2021-01-2915.04×2020-09-30
2021-02-268.96×2020-12-31
2021-03-3110.32×2020-12-31
2021-04-3010.63×2020-12-31
2021-05-2810.8×2021-03-31
2021-06-309.89×2021-03-31
2021-07-309.57×2021-03-31
2021-08-318.96×2021-06-30
2021-09-308.47×2021-06-30
2021-10-299.04×2021-06-30
2021-11-307.73×2021-09-30
2021-12-319.25×2021-09-30
2022-01-319.28×2021-09-30
2022-02-2814.61×2021-12-31
2022-03-3114.72×2021-12-31
2022-04-2915.16×2021-12-31
2022-05-3116×2022-03-31
2022-06-3015.72×2022-03-31
2022-07-2916.42×2022-03-31
2022-08-3116.47×2022-06-30
2022-09-3016.12×2022-06-30
2022-10-3118.77×2022-06-30
2022-11-3015.29×2022-09-30
2022-12-3015.4×2022-09-30
2023-01-3114.72×2022-09-30
2023-02-2813.38×2022-12-31
2023-03-3111.7×2022-12-31
2023-04-2811.6×2022-12-31
2023-05-3110.96×2023-03-31
2023-06-3012.43×2023-03-31
2023-07-3113.07×2023-03-31
2023-08-3112.33×2023-06-30
2023-09-2912.77×2023-06-30
2023-10-3113.8×2023-06-30
2023-11-3014.73×2023-09-30
2023-12-2916.78×2023-09-30
2024-01-3116.86×2023-09-30
2024-02-2918.83×2023-09-30
2024-03-2820.72×2023-12-31
2024-04-3020.37×2023-12-31
2024-05-3127.27×2024-03-31
2024-06-2826.16×2024-03-31
2024-07-3127.59×2024-03-31
2024-08-3028.63×2024-03-31
2024-09-3027.42×2024-03-31
2024-10-3124.91×2024-03-31
2024-11-2926.73×2024-03-31
2024-12-3121.85×2024-03-31
2025-01-3123.28×2024-03-31
2025-02-2824.98×2024-12-31
2025-03-3126.61×2024-12-31
2025-04-3027.51×2024-12-31
2025-05-3025.61×2024-12-31
2025-06-3026.74×2024-12-31
2025-07-3121.63×2024-12-31
2025-08-2924.34×2024-12-31
2025-09-3023.32×2024-12-31
2025-10-3110.64×2025-09-30
2025-11-2812.07×2025-09-30
2025-12-3111.98×2025-09-30
2026-01-3011.93×2025-09-30
2026-02-2712.93×2025-12-31
2026-03-3111.9×2025-12-31
2026-04-3012.96×2025-12-31
2026-05-29—2026-03-31
2026-06-30—2026-03-31
2026-07-31—2026-06-30
2026-08-31—2026-06-30
2026-09-25—2026-06-30
Mean 16.27×Median 14.95×

ROE

% · Annual / TTM

—
Cigna Group ROE. Reported fiscal history.
Fiscal period% · Annual / TTM
FY 2019 Q1—
FY 2019 Q2—
FY 2019 Q3—
FY 2019 Q4—
FY 2020 Q111.24%
FY 2020 Q211.54%
FY 2020 Q311.43%
FY 2020 Q417.68%
FY 2021 Q118.1%
FY 2021 Q216.97%
FY 2021 Q317.57%
FY 2021 Q411.01%
FY 2022 Q111.43%
FY 2022 Q211.58%
FY 2022 Q314.31%
FY 2022 Q414.5%
FY 2023 Q114.91%
FY 2023 Q214.57%
FY 2023 Q311.69%
FY 2023 Q411.34%
FY 2024 Q18.45%
FY 2024 Q28.55%
FY 2024 Q36.92%
FY 2024 Q47.87%
FY 2025 Q112.37%
FY 2025 Q212.31%
FY 2025 Q314.65%
FY 2025 Q414.4%
FY 2026 Q1—
FY 2026 Q2—

Capital allocation

% of tracked cash uses

$689M
Cigna Group capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2019 Q111.67% · $194M0.36% · $6M27.8% · $462MUnavailable60.17% · $1,000M100% · $1,662M
FY 2019 Q212.38% · $303M0% · $0M16.51% · $404MUnavailable71.11% · $1,740M100% · $2,447M
FY 2019 Q316.02% · $243M0% · $0M44.43% · $674MUnavailable39.55% · $600M100% · $1,517M
FY 2019 Q415.09% · $310M7.15% · $147M21.75% · $447MUnavailable56.01% · $1,151M100% · $2,055M
FY 2020 Q1Unavailable0% · $0M18.51% · $956M0% · $0M81.49% · $4,209M100% · $5,165M
FY 2020 Q2Unavailable0% · $0M37.86% · $368M1.54% · $15M60.6% · $589M100% · $972M
FY 2020 Q3Unavailable4.14% · $135M31.51% · $1,028M0% · $0M64.35% · $2,099M100% · $3,262M
FY 2020 Q4Unavailable0.14% · $4M59.42% · $1,690M0% · $0M40.44% · $1,150M100% · $2,844M
FY 2021 Q1UnavailableUnavailable38.08% · $2,794M4.7% · $345M57.22% · $4,199M100% · $7,338M
FY 2021 Q2UnavailableUnavailable55.96% · $916M20.89% · $342M23.15% · $379M100% · $1,637M
FY 2021 Q3Unavailable0% · $0M88.78% · $2,611M11.22% · $330M0% · $0M100% · $2,941M
FY 2021 Q4UnavailableUnavailable81.43% · $1,421M18.57% · $324M0% · $0M100% · $1,745M
FY 2022 Q1UnavailableUnavailable79.3% · $1,368M20.7% · $357M0% · $0M100% · $1,725M
FY 2022 Q2UnavailableUnavailable74.08% · $1,006M25.92% · $352M0% · $0M100% · $1,358M
FY 2022 Q3Unavailable0% · $0M91.12% · $3,500M8.88% · $341M0% · $0M100% · $3,841M
FY 2022 Q4Unavailable0% · $0M67.51% · $1,733M13.01% · $334M19.48% · $500M100% · $2,567M
FY 2023 Q1UnavailableUnavailable68.23% · $962M26.1% · $368M5.67% · $80M100% · $1,410M
FY 2023 Q2UnavailableUnavailable29.84% · $154M70.16% · $362M0% · $0M100% · $516M
FY 2023 Q3UnavailableUnavailable16.11% · $624M9.35% · $362M74.54% · $2,887M100% · $3,873M
FY 2023 Q4Unavailable0.44% · $4M60.04% · $544M39.51% · $358M0% · $0M100% · $906M
FY 2024 Q1UnavailableUnavailable60.64% · $4,022M6.05% · $401M33.32% · $2,210M100% · $6,633M
FY 2024 Q2UnavailableUnavailable45.58% · $990M18.05% · $392M36.37% · $790M100% · $2,172M
FY 2024 Q3UnavailableUnavailable0% · $0M100% · $390M0% · $0M100% · $390M
FY 2024 Q4UnavailableUnavailable84.04% · $2,022M15.96% · $384M0% · $0M100% · $2,406M
FY 2025 Q1UnavailableUnavailable57.56% · $1,508M15.73% · $412M26.72% · $700M100% · $2,620M
FY 2025 Q2UnavailableUnavailable46.08% · $1,112M16.62% · $401M37.3% · $900M100% · $2,413M
FY 2025 Q3UnavailableUnavailable0% · $0M90.34% · $402M9.66% · $43M100% · $445M
FY 2025 Q4Unavailable0% · $0M25.34% · $1,001M10.02% · $396M64.64% · $2,554M100% · $3,951M
FY 2026 Q1UnavailableUnavailable0% · $0M43.12% · $417M56.88% · $550M100% · $967M
FY 2026 Q2UnavailableUnavailable40.64% · $280M59.36% · $409M0% · $0M100% · $689M

Tracked cash uses · SBC excluded

Sources and calculations

Company filings · USD · Last checked 2026-10-18. Missing inputs remain unavailable. Your chart selection and layout are saved in this browser for Cigna Group.

All charts share the selected dates. Quarterly/Yearly changes fiscal charts; valuation keeps completed daily closes on a published TTM basis. Later restatements can delay that basis. Historical mean, median and pricing labels use the selected range and do not estimate intrinsic fair value.

Revenue
Reported revenue from company filings.
Net income
Reported company figures.
Net margin
Reported net income / revenue × 100.
P/E
Completed closing price × diluted shares / TTM earnings attributable to common shareholders.
ROE
Earnings attributable to owners / average equity attributable to owners × 100, using period end and one year earlier.
Capital allocation
Reported cash uses as a percentage of tracked uses. Missing categories remain unavailable; SBC is noncash and excluded.
Reported revenue and sources